Trina Maureen Sheedy, PA
Physician Assistant · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Trina Maureen Sheedy’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$16,299
Medicare paid this office $16,299 for 158 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of voice box using a flexible endoscope | 84 | $4,100 | $45 |
| Return visit (30+ min) | 36 | $2,526 | $65 |
| Long return visit (40+ min) | 14 | $1,642 | $109 |
| Short return visit (20+ min) | 32 | $1,451 | $44 |
| Short return visit | 49 | $1,176 | $22 |
See all 8 services
| Diagnostic exam of voice box using a flexible endoscope | 84 | $4,100 | $45 |
| Return visit (30+ min) | 36 | $2,526 | $65 |
| Long return visit (40+ min) | 14 | $1,642 | $109 |
| Short return visit (20+ min) | 32 | $1,451 | $44 |
| Short return visit | 49 | $1,176 | $22 |
| New patient visit (45+ min) | 15 | $1,145 | $76 |
| Ultrasound scan of head and neck soft tissue | 57 | $1,026 | $17 |
| Diagnostic exam of nasal passages using an endoscope | 11 | $392 | $36 |
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
158 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 12% · Women 42% · Also on Medicaid 27% · Health risk score 1.78. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 61% · Coronary heart disease 20% · Chronic kidney disease 20% · Cancer 20% · Diabetes 16% · Atrial fibrillation 16% · Depression 16% · COPD 14% · Heart failure 11% · Stroke 7%.
The office billed $194,092, Medicare allowed $23,878 and paid $16,299; for 365 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 158 | 365 | 73 | 1.78 | $194,092 | $16,299 |
| 2023 | 208 | 473 | 73 | 1.61 | $250,684 | $25,200 |
| 2022 | 171 | 302 | 72 | 1.58 | $175,607 | $15,642 |
| 2021 | 208 | 395 | 73 | 1.67 | $259,336 | $21,625 |
| 2020 | 134 | 271 | 72 | 1.77 | $184,548 | $14,666 |
| 2019 | 167 | 336 | 71 | 1.84 | $223,973 | $18,133 |
| 2018 | 213 | 455 | 71 | 1.71 | $298,587 | $25,889 |
| 2017 | 184 | 368 | 71 | 1.49 | $228,346 | $22,212 |
| 2015 | 19 | 33 | 71 | 0.68 | $6,102 | $1,934 |
| 2014 | 11 | 20 | 70 | 0.82 | $2,831 | $794 |
| 2013 | 129 | 146 | 75 | 1.48 | $59,994 | $11,199 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Diagnostic exam of voice box using a flexible endoscope | 99 | $5,863 | $52 |
| Return visit (30+ min) | 46 | $3,245 | $65 |
| New patient visit (45+ min) | 28 | $2,752 | $98 |
| Short return visit (20+ min) | 50 | $2,423 | $48 |
| Long return visit (40+ min) | 19 | $2,419 | $105 |
| New patient visit (60+ min) | 16 | $2,087 | $130 |
| Ultrasound scan of head and neck soft tissue | 75 | $1,564 | $19 |
| Short return visit | 48 | $1,228 | $25 |
| New patient visit (30+ min) | 17 | $1,065 | $63 |
2022: 8 services
| Diagnostic exam of voice box using a flexible endoscope | 60 | $3,325 | $50 |
| Return visit (30+ min) | 30 | $2,155 | $67 |
| Short return visit (20+ min) | 43 | $2,116 | $48 |
| New patient visit (45+ min) | 18 | $1,828 | $102 |
| Short return visit | 49 | $1,305 | $24 |
| New patient visit (30+ min) | 13 | $791 | $61 |
| Diagnostic exam of nasal passages using an endoscope | 16 | $675 | $42 |
| Ultrasound scan of head and neck soft tissue | 17 | $315 | $19 |
2021: 10 services
| Diagnostic exam of voice box using a flexible endoscope | 74 | $4,045 | $48 |
| Return visit (30+ min) | 53 | $3,453 | $63 |
| Short return visit (20+ min) | 52 | $2,635 | $49 |
| New patient visit (60+ min) | 16 | $2,474 | $155 |
| New patient visit (45+ min) | 17 | $1,585 | $93 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 11 | $1,454 | $121 |
| Short return visit | 43 | $1,269 | $28 |
| Diagnostic exam of nasal passages using an endoscope | 25 | $1,176 | $45 |
| New patient visit (30+ min) | 15 | $955 | $64 |
| Ultrasound scan of head and neck soft tissue | 38 | $785 | $18 |
2020: 8 services
| Return visit (30+ min) | 60 | $4,009 | $58 |
| Diagnostic exam of voice box using a flexible endoscope | 49 | $2,530 | $49 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 13 | $1,677 | $129 |
| New patient visit (45+ min) | 15 | $1,392 | $93 |
| Short return visit (20+ min) | 27 | $939 | $34 |
| Long return visit (40+ min) | 11 | $872 | $79 |
| Ultrasound scan of head and neck soft tissue | 40 | $798 | $19 |
| Diagnostic exam of nasal passages using an endoscope | 11 | $345 | $31 |
2019: 8 services
| Return visit (30+ min) | 79 | $4,603 | $55 |
| Diagnostic exam of voice box using a flexible endoscope | 69 | $3,682 | $48 |
| New patient visit (45+ min) | 21 | $1,859 | $89 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 13 | $1,709 | $122 |
| New patient visit (60+ min) | 11 | $1,389 | $126 |
| Short return visit (20+ min) | 32 | $1,154 | $36 |
| Ultrasound scan of head and neck soft tissue | 49 | $1,029 | $21 |
| New patient visit (30+ min) | 16 | $853 | $53 |
2018: 9 services
| Return visit (30+ min) | 103 | $7,189 | $59 |
| Diagnostic exam of voice box using a flexible endoscope | 79 | $4,285 | $50 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 19 | $3,436 | $127 |
| New patient visit (45+ min) | 24 | $2,327 | $97 |
| Short return visit (20+ min) | 55 | $2,209 | $37 |
| New patient visit (60+ min) | 11 | $1,393 | $127 |
| Ultrasound scan of head and neck soft tissue | 54 | $1,156 | $21 |
| New patient visit (30+ min) | 13 | $744 | $57 |
| Diagnostic exam of nasal passages using an endoscope | 14 | $731 | $49 |
2017: 8 services
| Diagnostic exam of voice box using a flexible endoscope | 74 | $4,278 | $53 |
| Return visit (30+ min) | 54 | $3,768 | $59 |
| New patient visit (60+ min) | 28 | $3,525 | $126 |
| New patient visit (45+ min) | 28 | $2,744 | $98 |
| Short return visit (20+ min) | 51 | $2,284 | $39 |
| Ultrasound scan of head and neck soft tissue | 37 | $819 | $22 |
| Diagnostic exam of nasal passages using an endoscope | 13 | $696 | $50 |
| New patient visit (30+ min) | 11 | $634 | $58 |
2013: 3 services
| Emergency department visit with high level of medical decision making | 48 | $5,233 | $107 |
| Emergency department visit with moderate level of medical decision making | 50 | $3,721 | $74 |
| Emergency department visit with low level of medical decision making | 25 | $1,012 | $40 |
Drugs they prescribed that Part D paid
$1,863
Pharmacies billed $1,863 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 17% of their Part D prescriptions (17 of 100) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
89 generic and fewer than 11 brand-name prescriptions · $1,863 in drug cost · 12 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluticasone Propionate | 12 | $162 | $14 |
| Oxycodone | 13 | $115 | $9 |
Year by year
| 2024 | 100 | 58 | 17% (17) | None | $1,863 |
| 2023 | 109 | 54 | 12% (13) | 0% | $3,662 |
| 2022 | 115 | 58 | 16% (18) | None | $2,827 |
| 2021 | 220 | 94 | 22% (49) | None | $5,605 |
| 2020 | 195 | 86 | 15% (29) | None | $5,214 |
| 2019 | 182 | 81 | 23% (42) | None | $7,552 |
| 2018 | 136 | 62 | 24% (32) | 16% | $5,864 |
| 2017 | 175 | 69 | 21% (36) | 10% | $5,845 |
| 2016 | 92 | 56 | 26% (24) | None | $3,346 |
| 2015 | 169 | 56 | 20% (34) | 14% | $3,865 |
| 2014 | 102 | 51 | 16% (16) | 29% | $3,626 |
| 2013 | 119 | 91 | 41% (49) | None | $1,843 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Amoxicillin-Clavulanate Potass | 25 | $1,305 | $52 |
| Pentoxifylline | 15 | $1,226 | $82 |
2022: 3 drugs
| Amoxicillin-Clavulanate Potass | 26 | $845 | $32 |
| Pentoxifylline | 18 | $694 | $39 |
| Sulfamethoxazole-Trimethoprim | 14 | $27 | $2 |
2021: 6 drugs
| Amoxicillin-Clavulanate Potass | 33 | $1,122 | $34 |
| Pentoxifylline | 34 | $800 | $24 |
| Lidocaine Hcl Viscous | 20 | $476 | $24 |
| Oxycodone | 20 | $341 | $17 |
| Hydrocodone-Acetaminophen | 20 | $265 | $13 |
| Clindamycin | 11 | $178 | $16 |
2020: 2 drugs
| Amoxicillin-Clavulanate Potass | 34 | $1,148 | $34 |
| Pentoxifylline | 42 | $813 | $19 |
2019: 5 drugs
| Narcan | 13 | $1,690 | $130 |
| Amoxicillin-Clavulanate Potass | 26 | $748 | $29 |
| Pentoxifylline | 27 | $580 | $21 |
| Oxycodone | 23 | $449 | $20 |
| Hydrocodone-Acetaminophen | 14 | $138 | $10 |
2018: 3 drugs
| Oxycodone | 21 | $1,716 | $82 |
| Amoxicillin-Clavulanate Potass | 12 | $433 | $36 |
| Levothyroxine | 11 | $371 | $34 |
2017: 4 drugs
| Oxycodone | 20 | $1,119 | $56 |
| Amoxicillin-Clavulanate Potass | 23 | $596 | $26 |
| Pentoxifylline | 24 | $452 | $19 |
| Levothyroxine | 12 | $226 | $19 |
2016: 2 drugs
| Oxycodone | 15 | $831 | $55 |
| Levothyroxine | 12 | $191 | $16 |
2015: 8 drugs
| Oxycodone | 14 | $814 | $58 |
| Hydrocodone-Acetaminophen | 16 | $246 | $15 |
| Ciprofloxacin | 14 | $199 | $14 |
| Pentoxifylline | 14 | $196 | $14 |
| Levothyroxine | 12 | $181 | $15 |
| Omeprazole | 11 | $143 | $13 |
| Alendronate | 11 | $133 | $12 |
| Prednisone | 17 | $47 | $3 |
2014: 2 drugs
| Levothyroxine | 24 | $355 | $15 |
| Fluticasone Propionate | 14 | $296 | $21 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 19 | $109 | $6 |
| Oxycodone-Acetaminophen | 17 | $63 | $4 |
Money from drug and device companies
$701 in 2025
| 2025 | 5 | 6 | None | $701 |
| 2024 | 5 | 6 | None | $653 |
| 2023 | 2 | 2 | None | $166 |
| 2022 | 3 | 5 | None | $420 |
| 2021 | 1 | 1 | None | $119 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| DePuy Synthes Sales | Matrixmandible | $193 | 2 payments
|
| Teva Pharmaceuticals USA | None | $132 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $130 | 1 payment
|
| Lilly USA | Zepbound | $123 | 1 payment
|
| ViiV Healthcare | Apretude | $122 | 1 payment
|
See all 6 published payments
| Madrigal Pharmaceuticals | Meals · 2025-11-20 | Rezdiffra | $130 |
| DePuy Synthes Sales | Meals · 2025-10-29 | Trumatch | $46 |
| DePuy Synthes Sales | Meals · 2025-08-08 | Matrixmandible | $147 |
| Lilly USA | Meals · 2025-07-17 | Zepbound | $123 |
| Teva Pharmaceuticals USA | Meals · 2025-05-15 | None | $132 |
| ViiV Healthcare | Meals · 2025-03-13 | Apretude | $122 |
See earlier years (2024, 2023, 2022, 2021)
2024: $653
| Abbvie | Vraylar | $257 | 2 payments
|
| Genzyme | Fabrazyme | $144 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $110 | 1 payment
|
| Vertex Pharmaceuticals | None | $104 | 1 payment
|
| Optinose US | Xhance | $39 | 1 payment
|
2023: $166
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $131 | 1 payment
|
| Genzyme | Fabrazyme | $35 | 1 payment
|
2022: $420
| Abbvie | Skyrizi | $247 | 2 payments
|
| Stryker | Audion Et Dilation System | $91 | 2 payments
|
| Biogen | None | $82 | 1 payment
|
2021: $119
| GlaxoSmithKline | Zejula | $119 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1275884355
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
- Mailing address
- 2340 Clay St Fl 5, San Francisco, CA, 94115
- NPI first listed
- 2012-09-28
- NPI last updated
- 2025-06-24
- NPI record certified
- 2025-06-24
This is when the NPI record was last certified, not a medical board exam.